Atlas Trials

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Clinical trial NCT03365947 · COMPLETED

Trial details

NCT number
NCT03365947
Sponsor
Arrowhead Pharmaceuticals
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatitis B
Start date
2018-03-27
Primary completion
2020-04-23
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.